As shown here, CMap analysis of the TGFβ-induced Tks5+/- LFs profile identified, among established and promising others, src inhibition as a possible treatment to limit LF invasion (Fig. 7) and therefore pulmonary fibrosis. The gene discussed is SRC; the disease is pulmonary fibrosis.